In the UK it is estimated that more than 325,000 people living with chronic hepatitis B, and the risk of developing a scarring of the liver and potentially cancer.9.. Tenofovir received approval in the European Union for the treatment of chronic hepatitis B infection in adults in April 2008 and has already designed for use in Scotland and Wales from two independent Health Care Technology Assessment groups. 6 Decision nICE is permitted now to patients in England have the same access to those who must have had in Scotland and Wales for almost a year. The drug has a well-established safety profile of more than 2 million patient-years of safety data from extensive clinical experience intended for the treatment of acquired HIV.7 There is no cure for hepatitis B infection, but it is completely preventable through vaccination, In addition,ople remain susceptible to infection with the hepatitis B virus up to up to 100 times more easily than HIV-1.8 transmit the virus in the blood and other body fluids, and through casual contact.
3 resistance is a common barrier to successful long-term therapy with tenofovir is the only antiviral agent for the treatment of hepatitis B treatment, which shows in their pivotal trial studies, no resistance after two years.4.. Source: Sherri McGinnis Gonz lez University of Illinois at Chicago?NICE recommends Viread for the treatment of chronic hepatitis B, UKThe National Institute for Health and Clinical Excellence was last issued guidelines recommend the use of Viread for the treatment of chronic hepatitis B virus infection in adults.1 VIREAD is an oral antiviral medication that of of hepatitis B virus and has demonstrated at least as effective as other currently recommended options and an affordable antiviral strategy.1 in both treatment-na? ve and treatment-experienced patients, tenofovir has shown consistent efficacy for up to two years.Scientists conclude Restless legs syndrome is a common condition among the general population. Do you feel been restless legs disease can be treated effectively, the medical profession and the public need be better informed about the disease.
New research to referred to a better understanding of the common condition restless legs syndrome.
Researchers report the prevalence of restless legs syndrome was 10.6 per cent. They found prevalence of increase with age and women were twice as probably have to his than men. Also Also, report by researchers risk of restless legs syndrome in women, children had increased. More children Women from bare , the more likely she to the are restless legs syndrome.